Oral Contraceptives Increase Risk for Breast Cancer in Some Women

	Tweet

A meta-analysis published in the October issue of Mayo Clinic Proceedings indicts oral contraceptives as putting premenopausal women at significantly increased risk for breast cancer, especially women who use them prior to having a child.

The meta-analysis builds on many studies with similar findings. But even as the findings stack up, many women are unaware of the risks posed by oral contraceptive use prior to pregnancy, says lead study author Chris Kahlenborn, M.D., of Altoona Hospital in Altoona, Pa.

Dr. Kahlenborn says the discrepancy between risk and patient awareness prompted the meta-analysis, which involved extracting data from 34 studies on whether oral contraceptive (OC) use is associated with premenopausal breast cancer. Included in the studies were women who were premenopausal or younger than 50 and who had been, in most cases, diagnosed with breast cancer during or after 1980.

“As I studied the medical literature, I noticed that a trend appeared,” says Dr. Kahlenborn. “Namely, OC use prior to first-term pregnancy seemed to consistently increase the risk of premenopausal breast cancer. Although the trend was apparent, premenopausal women have continued to hear that OCs are basically safe.”

Rather, patients should know that sustained oral contraceptive use prior to pregnancy increases a premenopausal woman’s risk of developing breast cancer, saysDr. Kahlenborn. He says physicians should better inform their patients of the risks associated with oral contraceptives and calls it a “clear-cut informed consent issue.”

The study noted that 21 out of 23 retrospective studies have shown an increased risk of breast cancer in women who took oral contraceptives prior to pregnancy. It also showed that those women experienced an increased risk of 44 percent.

What’s more, in 2005, the World Health Organization officially classified oral contraceptives as a class one carcinogen, the study’s authors say.

These are staggering results given that more that more than 45,000 women each year develop breast cancer prior to menopause, Dr. Kahlenborn says.

“My hope is that physicians will provide more detailed information to their patients about hormonal contraceptives,” he says. “The authors of our meta-analysis believe that women deserve to be fully informed.”

Other authors of the meta-analysis study are Francesmary Modugno, Ph.D., and Douglas Potter, Ph.D., both of the University of Pittsburgh Cancer Institute, and Walter Severs, Ph.D., of Pennsylvania State University in University Park.

A peer-review journal, Mayo Clinic Proceedings publishes original articles and reviews dealing with clinical and laboratory medicine, clinical research, basic science research and clinical epidemiology. Mayo Clinic Proceedings is published monthly by Mayo Foundation for Medical Education and Research as part of its commitment to the medical education of physicians. The journal has been published for more than 80 years and has a circulation of 130,000 nationally and internationally.

RELATED STORIES:
How women can improve their quality of life after breast cancer treatment   Future in which Breast Cancer Will Be Cured or Controlled   Perceptions of cancer care may not match reality   Extra Radiation Dose Prevents Breast Cancer Return in Young Women   Unsuspected protein determines resistance to breast cancer treatment   Peptide Delivers One-Two Punch to Breast Cancer in Pre-Clinical Study   Targeted Immunotherapy: Metastatic Breast, Pancreatic Cancers   Hormone Sensitivity of Breast Stem Cells Presents Drug Target   Study finds race affects African American survival of breast cancer   Plant-Based Diets May Improve Breast Cancer Survival   New ‘stealth’ drugs give hope in fight on cancer   Breast cancer treatment knowledge lacking   Studies Point To Strategies for Reducing Painful Breast Cancer Drug Side Effects   Fox Chase researchers uncover Achilles’ heel in aggressive breast tumors   Dieting reduces lymphedema after breast cancer   98 percent of elective mastectomy patients would have reconstruction again, says ASPS study   Study Questions “Cancer Stem Cell” Hypothesis in Breast Cancer   Study determines costs of breast and cervical cancer detection among low-income women   Landmine detection technology adapted to screen for breast cancer   Dense breasts linked to return of breast cancer   Breast cancer deaths decline more slowly for some   FDA panels put silicone breast implants back under microscope

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]